• Mon, February 29, 2016
  • Fri, February 26, 2016
  • Tue, March 1, 2016
  • Wed, March 2, 2016

Gena Wang Maintained (BMRN) at Buy with Decreased Target to $105 on, Feb 26th, 2016

Gena Wang of Barclays, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $125 to $105 on, Feb 26th, 2016.

Gena has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.



This is the rating of the analyst that currently disagrees with Gena


  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $120 on, Tuesday, February 23rd, 2016

Like: 👍